Stocktoria
Acrivon Therapeutics, Inc. ACRV
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-11-15
Acrivon Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 767,020 | $4.4M | 1.99% |
| RENAISSANCE TECHNOLOGIES LLC | 758,863 | $1.4M | 1.97% |
| TWO SIGMA INVESTMENTS, LP | 641,498 | $1.1M | 1.67% |
| CITADEL ADVISORS LLC | 41,276 | $73,471 | 0.11% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.